Staples and Office Depot took their merger case directly to customers on Friday, saying in an open letter that the US government is “simply wrong” for blocking their proposed deal.
More than a year ago, Staples offered to buy Office Depot in a transaction then valued at about $5.5 billion, pressured by declining sales in the office supplies sector and the rise of rivals, most notably Amazon.com and W.B. Mason.
But the Federal Trade Commission sued to block the deal, arguing it would severely curtail competition in the “consumables” space. The FTC is trying to win a preliminary order from a federal judge to prevent the merger so that the agency can proceed with an administrative trial in May. A hearing is set for Monday in U.S. District Court.
“The FTC’s actions to stop this transaction are based on a flawed analysis of the marketplace and a deep misunderstanding of the competitive landscape,” the CEOs of Staples and Office Depot, Ron Sargent and Roland Smith, say in the joint letter.
They later conclude: “The FTC is simply wrong. The combination of Staples and Office Depot is good for customers.”
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas